Understand the clinical journey for patients with Vitiligo

Challenge

As objective disease severity scales (VASI, DLQI) are not often collected in real-world clinical practice, longitudinal therapeutic escalation can serve as a good surrogate for disease severity.

Solution

Leverage OM1 linked, deep clinical and claims data to illustrate the longitudinal clinical treatment progression and associated outcomes.

*Counts through Q2 2022

Vitiligo patients with diagnosis and linked EMR and claims data including notes from dermatologists